Table 3.
Comparative evaluation of various lesions in magnetic resonance imaging, F-18 fluorocholine positron emission tomography-computed tomography, and Tc-99m methylene-diphosphonate bone scan
| Site of involvement | Number of patients (number of lesions) | |
|---|---|---|
| Initial staging | Recurrence | |
| Pelvic lymph nodes | ||
| MRI | 2 | 15 |
| F-18 FCH PET/CT | 7 | 18 |
| Pelvic bone metastasis | ||
| MRI | 1 | 8 |
| Tc-99m MDP | 1 | 9 |
| F-18 FCH PET/CT | 2 | 9 |
| Other sites of bone metastasis | ||
| Tc-99m MDP | 2 (8) | 10 (34) |
| F-18 FCH PET/CT | 2 (9) | 11 (46) |
| Additional sites on F-18 FCH | ||
| Abdominal lymph node | 2 | 10 |
| Lung lesion | 0 | 2 |
FCH: Fluorocholine, MRI: Magnetic resonance imaging, PET/CT: Positron emission tomography-computed tomography, MDP: Methylene-diphosphonate